The 4-7-8 Breathing Technique on Pain and Nausea-Vomiting
Pain
Effect of the 4-7-8 Breathing Technique on Pain and Nausea-Vomiting in Patients After Bariatric Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
This study is planned as a randomized controlled trial to determine the effect of the 4-7-8 breathing technique applied to patients after bariatric surgery on pain and nausea and vomiting. The research will be conducted on 60 patients who underwent bariatric surgery between 05.2024-12.2024. Randomization will be ensured for students who meet the inclusion criteria, and they will be divided into two random groups: the experimental group (n=30) and the control group (n=30). After obtaining consent with the "Informed Consent Form," patients who agree to participate in the study will have the "Patient Introduction Form" filled out by researchers, and they will be provided with training on the 4-7-8 breathing technique. Patients will be instructed to practice the 4-7-8 breathing technique once per hour (4 breaths) post-surgery. Pain and nausea-vomiting will be monitored at 0, 2, 6, 12, and 24 hours during their 24-hour hospital stay. The control group, after consenting with the "Informed Consent Form" the day before surgery, will have the "Patient Introduction Form" filled out by researchers, and their pain and nausea-vomiting status will be monitored at the same intervals during their hospital stay. No interventions will be made for the control group; they will receive routine nursing care during their hospital stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Apr 2025
Shorter than P25 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedStudy Start
First participant enrolled
April 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedOctober 2, 2025
September 1, 2025
22 days
May 13, 2024
September 29, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Pain Scale
During the 24-hour hospital stay, the patient's pain level will be assessed at 0, 2, 6, 12, and 24 hours, and the pain intensity, ranging from 0 for no pain to 10 for severe pain, as indicated by the patient, will be recorded.
just before operation, just after operation
Vomitting
During the 24-hour hospital stay, the patient's nausea level will be observed at 0, 2, 6, 12, and 24 hours, and the occurrence of vomiting, noted as either present or absent, will be recorded.
just before operation, just after operation
Nausea
During the 24-hour hospital stay, the patient's nausea level will be assessed at 0, 2, 6, 12, and 24 hours, and the severity of nausea, ranging from 0 for no nausea to 10 for severe nausea as indicated by the patient, will be recorded.
just before operation, just after operation
Study Arms (2)
4-7-8 Breathing Technique
EXPERIMENTALThe Patient Introduction Form comprises three sections. The first section covers sociodemographic characteristics, including gender, age, BMI, education level, smoking status, and family history of obesity (6 questions). The second section addresses medical characteristics such as chronic diseases, ASA score, duration of general anesthesia, type of surgery, surgical complications history, and length of hospital stay (7 questions). The third section evaluates pain and nausea-vomiting using the Visual Analog Scale, a 10 cm horizontal line where patients mark their severity level. Scores range from 0-10, with higher scores indicating increased symptom severity. The scale is versatile, assessing symptoms like pain, anxiety, fatigue, and nausea-vomiting, with vomiting assessed as "present" or "absent." Patients will be taught the 4-7-8 breathing technique pre-surgery and asked to practice it post-surgery. Their responses to the third section's questions will be recorded.
Control
NO INTERVENTIONThe Patient Introduction Form comprises three sections: 1. Sociodemographic characteristics, encompassing gender, age, BMI, education level, smoking status, and family history of obesity (6 questions). 2. Medical characteristics, including the presence of chronic diseases, ASA score, duration of general anesthesia, type of surgery performed, history of surgical complications, and length of hospital stay (7 questions). 3. Evaluation of pain and nausea-vomiting using the Visual Analog Scale, which entails a 10 cm horizontal line where patients mark their severity level. Scores range from 0-10, with higher scores indicating increased symptom severity. Vomiting will be assessed as "present" or "absent." Patients in the control group will undergo routine monitoring and treatments without interventions, and their responses to the questions from the third section will be recorded.
Interventions
Patients will be instructed to practice the 4-7-8 breathing technique once per hour (4 breaths) post-surgery. Pain and nausea-vomiting will be monitored at 0, 2, 6, 12, and 24 hours during their 24-hour hospital stay.
Eligibility Criteria
You may qualify if:
- Being aged 18 and above, and under 65 years old
- Patients undergoing laparoscopic general surgery under general anesthesia (such as laparoscopic sleeve gastrectomy, Laparoscopic Roux-en-Y gastric bypass) will be included in the study.
- Having an ASA Score of I or II
- Being willing to participate in the study
You may not qualify if:
- Not undergoing laparoscopic surgical intervention,
- Having neurological or psychological issues,
- Transferred to the intensive care unit after surgery,
- Emergency and unplanned cases,
- Patients diagnosed with cancer will be excluded from the scope of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara YBU
Yenimahalle, Ankara, 6010, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ankara Yildirim Beyazıt University
Study Record Dates
First Submitted
May 13, 2024
First Posted
June 3, 2024
Study Start
April 8, 2025
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
October 2, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share